Cargando…
COVID-19 and lung cancer: update on the latest screening, diagnosis, management and challenges
Lung cancer, considered one of the most common causes of cancer deaths worldwide, is a complex disease with its own challenges. The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), compounded these challenges and forced the medical...
Autores principales: | Moubarak, Simon, Merheb, Diala, Basbous, Lynn, Chamseddine, Nathalie, Bou Zerdan, Maroun, Assi, Hazem I |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515530/ https://www.ncbi.nlm.nih.gov/pubmed/36154328 http://dx.doi.org/10.1177/03000605221125047 |
Ejemplares similares
-
Latest updates on cellular and molecular biomarkers of gliomas
por: Bou Zerdan, Maroun, et al.
Publicado: (2022) -
Role of circulating tumor DNA and circulating tumor cells in breast cancer: History and updates
por: Chedid, Julien, et al.
Publicado: (2022) -
Clinical Significance of Breast Cancer Molecular Subtypes and Ki67 Expression as a Predictive Value for Pathological Complete Response following Neoadjuvant Chemotherapy: Experience from a Tertiary Care Center in Lebanon
por: Atoui, Ali, et al.
Publicado: (2022) -
Metabolic Syndrome: Updates on Pathophysiology and Management in 2021
por: Fahed, Gracia, et al.
Publicado: (2022) -
Oligodendroglioma: A Review of Management and Pathways
por: Bou Zerdan, Maroun, et al.
Publicado: (2021)